Low riskFDA DrugClass III

Ascend dabigatran capsules recalled for impurity specification failure

Ascend Laboratories is recalling one lot of dabigatran etexilate capsules, 150 mg, after an out-of-specification result in stability testing for Impurity II, Impurity III, and total impurities at 12 months. About 2,717 cartons were distributed nationwide by Major Pharmaceuticals. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Ascend Laboratories recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check the carton for lot 25141584 and expiration date 4/30/2027 (NDC 0904-7255-10, 20-count carton, 2x10).
  3. The notice doesn't say how to get a refund or replacement; ask Major Pharmaceuticals or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
2,717 cartons
Illnesses reported
None reported
Manufactured in
135 Us Highway 202 206 Ste 15, N/A, Bedminster, NJ, United States
Classification
Class III
Recall number
D-0736-2026

In the FDA's words

Description
Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7255-10. Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability. Lot: 25141584, Exp 4/30/2027. Distribution: USA Nationwide Affected quantity: 2,717 cartons
Hazard
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

2 products in this recall

The agency lists each product separately. Check every one you might have.

More from Ascend Laboratories

See all

Related topics

Industrial chemicalsOtherDrugsSold nationwideMore from FDA Drug